Exchange Traded Concepts, LLC United Therapeutics Corp Transaction History

Exchange Traded Concepts, LLC

  • $4.74 Billion
  • Q4 2024

A detailed history of Exchange Traded Concepts, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 4,062 shares of UTHR stock, worth $1.51 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,062
Previous 4,136 1.79%
Holding current value
$1.51 Million
Previous $1.48 Million 3.31%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
SELL
$348.66 - $410.0 $25,800 - $30,340
-74 Reduced 1.79%
4,062 $1.43 Million
Q3 2024

Oct 10, 2024
SELL
$311.04 - $363.55 $361,428 - $422,445
-1,162 Reduced 21.93%
4,136 $1.48 Million
Q2 2024

Aug 13, 2024
SELL
$228.26 - $319.04 $144,716 - $202,271
-634 Reduced 10.69%
5,298 $1.69 Million
Q1 2024

Apr 15, 2024
BUY
$210.76 - $249.51 $671,692 - $795,188
3,187 Added 116.1%
5,932 $1.36 Million
Q4 2023

Jan 05, 2024
BUY
$214.88 - $256.94 $45,124 - $53,957
210 Added 8.28%
2,745 $603,000
Q3 2023

Oct 18, 2023
SELL
$211.82 - $248.24 $25,206 - $29,540
-119 Reduced 4.48%
2,535 $572,000
Q2 2023

Jul 20, 2023
BUY
$205.19 - $232.99 $21,544 - $24,463
105 Added 4.12%
2,654 $585,000
Q1 2023

Apr 12, 2023
SELL
$212.99 - $276.17 $60,489 - $78,432
-284 Reduced 10.02%
2,549 $570,000
Q4 2022

Jan 17, 2023
BUY
$205.95 - $280.43 $15,446 - $21,032
75 Added 2.72%
2,833 $788,000
Q3 2022

Oct 07, 2022
SELL
$203.3 - $244.17 $46,555 - $55,914
-229 Reduced 7.67%
2,758 $577,000
Q2 2022

Jul 20, 2022
BUY
$174.81 - $241.14 $11,887 - $16,397
68 Added 2.33%
2,987 $704,000
Q1 2022

Apr 26, 2022
BUY
$166.16 - $213.96 $14,289 - $18,400
86 Added 3.04%
2,919 $524,000
Q4 2021

Jan 13, 2022
SELL
$184.32 - $216.08 $29,491 - $34,572
-160 Reduced 5.35%
2,833 $612,000
Q3 2021

Oct 18, 2021
BUY
$179.86 - $214.88 $8,813 - $10,529
49 Added 1.66%
2,993 $552,000
Q2 2021

Jul 30, 2021
SELL
$170.47 - $211.93 $26,252 - $32,637
-154 Reduced 4.97%
2,944 $528,000
Q1 2021

Apr 20, 2021
SELL
$153.94 - $174.85 $15,547 - $17,659
-101 Reduced 3.16%
3,098 $518,000
Q4 2020

Jan 19, 2021
BUY
$101.87 - $151.79 $31,885 - $47,510
313 Added 10.85%
3,199 $486,000
Q3 2020

Oct 30, 2020
BUY
$99.9 - $121.13 $17,782 - $21,561
178 Added 6.57%
2,886 $291,000
Q2 2020

Jul 15, 2020
BUY
$92.74 - $125.82 $251,139 - $340,720
2,708 New
2,708 $328,000

Others Institutions Holding UTHR

# of Institutions
679
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email